SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-298631
Filing Date
2023-12-19
Accepted
2023-12-19 16:22:56
Documents
15
Period of Report
2023-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d676870d8k.htm   iXBRL 8-K 33918
2 EX-10.1 d676870dex101.htm EX-10.1 1212568
3 EX-99.1 d676870dex991.htm EX-99.1 5721
7 GRAPHIC g676870g1219093149498.jpg GRAPHIC 2132
  Complete submission text file 0001193125-23-298631.txt   1671013

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20231219.xsd EX-101.SCH 2843
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20231219_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20231219_pre.xml EX-101.PRE 10808
9 EXTRACTED XBRL INSTANCE DOCUMENT d676870d8k_htm.xml XML 3216
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 231497581
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)